BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2003
View Archived Issues
Effective use of theophylline in the reduction of functional chest pain
Read More
Similar benefits found for rHuEPO and darbepoetin alfa in dialysis and renal anemia
Read More
Oxandrolone reported to prevent involuntary weight loss in cancer and HIV infection
Read More
Novel group I metabotropic glutamate antagonists identified by Roche researchers
Read More
Bayer patents two series of PDE4 inhibitors for COPD and asthma
Read More
Boehringer Ingelheim claims cytokine production inhibitors and their use
Read More
Lilly Icos team discovers new tetracyclic PDE5 inhibitors
Read More
New alphav integrin antagonists in Merck development pipeline
Read More
Vertex presents new inhibitors of CAK, a novel target in fungal infection therapy
Read More
PDE4 inhibitors for use in cognition disorders described by Memory Pharmaceuticals
Read More
CAT and OGS announce merger plans
Read More
Cangene awarded contract to develop hyperimmune globulin for botulinum toxin
Read More
PEG-Alfacon enters phase I study for HCV
Read More
Galen acquires U.S. rights to Sarafem
Read More
Helicon exercises option to license IPL-455903 from Inflazyme
Read More
Nabi-HB accepted for priority review for use in liver transplantation
Read More
rHu-KGF reduces severe oral mucositis in bone marrow transplant patients
Read More
Plant-produced alpha-galactosidase A receives orphan drug status for Fabry's disease
Read More
Pivotal OvaRex trials begin enrollment
Read More
KV-2920 incorporated into LDL may be useful for the therapy of atherosclerosis
Read More
d[Cha(4)]AVP: a high-affinity and selective vasopressin V1b receptor agonist
Read More
New class of polyglutamine aggregation inhibitors with potential in Huntington's disease
Read More
Safety study of Serevent halted
Read More